622 related articles for article (PubMed ID: 33478454)
1. Diffuse large B-cell lymphoma originating from the rectum and diagnosed after rectal perforation during the treatment of ulcerative colitis: a case report.
Suzuki T; Iwamoto K; Nozaki R; Saiki Y; Tanaka M; Fukunaga M; Yamada K
BMC Surg; 2021 Jan; 21(1):50. PubMed ID: 33478454
[TBL] [Abstract][Full Text] [Related]
2. Fate of the rectal stump after subtotal colectomy for ulcerative colitis in the era of ileal pouch-anal anastomosis.
Munie S; Hyman N; Osler T
JAMA Surg; 2013 May; 148(5):408-11. PubMed ID: 23677401
[TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma of the rectum in a patient with Crohn's disease.
Hardy AJ; Stoica I; Kearney DE; O'Riordain DS
BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32303524
[TBL] [Abstract][Full Text] [Related]
4. [Primary diffuse large B-cell lymphoma of the rectum simulating a rectal adenocarcinoma].
Marín García D; Cárdenas Lafuente F; Utrilla Ayala Mdel C; Galán Jurado MV; Jiménez Martín JJ; García Ordóñez MA
Gastroenterol Hepatol; 2010 Feb; 33(2):92-8. PubMed ID: 19875198
[TBL] [Abstract][Full Text] [Related]
5. [Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].
Quera R; Flores L; Simian D; Kronberg U; Vial MT; de Guevara DL; García-Rodríguez MJ
Rev Med Chil; 2017 Oct; 145(10):1342-1348. PubMed ID: 29488576
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine.
Sato K; Suga T; Hirayama A; Daikuhara S; Uehara T; Tanaka E
Clin J Gastroenterol; 2020 Feb; 13(1):1-5. PubMed ID: 31350718
[TBL] [Abstract][Full Text] [Related]
7. Clinical benefit of R-CHOP without splenectomy in stage I primary splenic diffuse large B-cell lymphoma.
Rajendran T; Kini JR; Abna A; Prasad K
BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 34983812
[TBL] [Abstract][Full Text] [Related]
8. A case of duodenal malignant lymphoma presenting as acute pancreatitis: systemic lupus erythematosus and immunosuppressive therapy as risk factors.
Yamada R; Sakuno T; Inoue H; Miura H; Takeuchi T; Shiono Y; Okuse H; Nakamura M; Katsurahara M; Hamada Y; Tanaka K; Horiki N; Takei Y
Clin J Gastroenterol; 2018 Aug; 11(4):286-290. PubMed ID: 29546569
[TBL] [Abstract][Full Text] [Related]
9. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Go SI; Park MJ; Song HN; Kim HG; Kang MH; Lee HR; Kim Y; Kim RB; Lee SI; Lee GW
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):567-576. PubMed ID: 27104110
[TBL] [Abstract][Full Text] [Related]
11. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
12. Treatment of gastrointestinal diffuse large B cell lymphoma in China: a 10-year retrospective study of 114 cases.
Li X; Shen W; Cao J; Wang J; Chen F; Wang C; Zou S; Shen B; Zhao R; Li J; Shen Z
Ann Hematol; 2012 Nov; 91(11):1721-9. PubMed ID: 22733613
[TBL] [Abstract][Full Text] [Related]
13. Jejunal perforation: a rare presentation of B-cell lymphoma.
Santharam V; Kumar P; Lee LY
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24557479
[TBL] [Abstract][Full Text] [Related]
14. Intestinal perforation secondary to intestinal diffuse large b-cell lymphoma in a patient with coeliac disease.
Ríos León R; Crespo Pérez L; Martínez-Geijo Román C; Barbado Cano A; García-Cosío Piqueras M; Sánchez Rodríguez E; de la Filia Molina IG; Flores de Miguel Á; Guerrero García A; López-Jiménez FJ; Mena Mateos A; Albillos Martínez A
Gastroenterol Hepatol; 2018 Oct; 41(8):503-504. PubMed ID: 29054322
[No Abstract] [Full Text] [Related]
15. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].
Liu P; Jiang SY; He XH; Qin Y; Gui L; Zhou SY; Yang JL; Yang S; Wen TY; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):234-241. PubMed ID: 32252203
[No Abstract] [Full Text] [Related]
16. Rare malignant ulcer related to primary intestinal diffuse large B-cell lymphoma: A case report.
Jia N; Tang Y; Li Y
Medicine (Baltimore); 2020 Feb; 99(6):e18590. PubMed ID: 32028388
[TBL] [Abstract][Full Text] [Related]
17. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
[TBL] [Abstract][Full Text] [Related]
18. Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
Kilani Y; Sohail H; Lim CY; Payette A; Kamal SAF; Afzal A; Khan T; Paracha N; Muppidi MR; Sittler D
Am J Case Rep; 2022 Sep; 23():e937500. PubMed ID: 36151707
[TBL] [Abstract][Full Text] [Related]
19. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
[TBL] [Abstract][Full Text] [Related]
20. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
